| PLIP: fully automated protein–ligand interaction profiler S Salentin, S Schreiber, VJ Haupt, MF Adasme, M Schroeder Nucleic acids research 43 (W1), W443-W447, 2015 | 704 | 2015 |
| From malaria to cancer: Computational drug repositioning of amodiaquine using PLIP interaction patterns S Salentin, MF Adasme, JC Heinrich, VJ Haupt, S Daminelli, Y Zhang, ... Scientific reports 7 (1), 1-13, 2017 | 21 | 2017 |
| Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs D Parisi, MF Adasme, A Sveshnikova, SN Bolz, Y Moreau, M Schroeder Computational and Structural Biotechnology Journal 18, 1043-1055, 2020 | 13 | 2020 |
| Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery SW Poser, O Otto, C Arps-Forker, Y Ge, M Herbig, C Andree, ... The FASEB Journal, 2019 | 5 | 2019 |
| Structure-based drug repositioning explains ibrutinib as VEGFR2 inhibitor MF Adasme, D Parisi, K Van Belle, S Salentin, VJ Haupt, GS Jennings, ... Plos one 15 (5), e0233089, 2020 | 4 | 2020 |
| Structure-based drug repositioning: Potential and limits MF Adasme, D Parisi, A Sveshnikova, M Schroeder Seminars in cancer biology, 2020 | 4 | 2020 |
| PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA MF Adasme, KL Linnemann, SN Bolz, F Kaiser, S Salentin, VJ Haupt, ... Nucleic Acids Research, 2021 | | 2021 |
| Toward an Understanding of Pan-Assay Interference Compounds and Promiscuity: A Structural Perspective on Binding Modes SN Bolz, MF Adasme, M Schroeder Journal of Chemical Information and Modeling, 2021 | | 2021 |
| Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning MF Adasme, SN Bolz, L Adelmann, S Salentin, VJ Haupt, ... International journal of molecular sciences 21 (22), 8809, 2020 | | 2020 |
Michael SchroederProfessor in Bioinformatics, TU DresdenBestätigte E-Mail-Adresse bei biotec.tu-dresden.de
